Lessee, Operating Lease, Liability, to be Paid, Year Four of Nurix Therapeutics, Inc. from 30 Nov 2021 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Nurix Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 30 Nov 2021 to 30 Nov 2025.
  • Nurix Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Nov 2025 was $14,248,000, a 364% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $14,248,000 +$11,174,000 +364% 30 Nov 2025 10-K 28 Jan 2026 2025 FY
Q4 2024 $3,074,000 +$81,000 +2.7% 30 Nov 2024 10-K 28 Jan 2025 2024 FY
Q4 2023 $2,993,000 +$323,000 +12% 30 Nov 2023 10-K 15 Feb 2024 2023 FY
Q4 2022 $2,670,000 +$932,000 +54% 30 Nov 2022 10-K 09 Feb 2023 2022 FY
Q3 2022 $2,670,000 31 Aug 2022 10-Q 06 Oct 2022 2022 Q3
Q2 2022 $2,670,000 31 May 2022 10-Q 07 Jul 2022 2022 Q2
Q4 2021 $1,738,000 30 Nov 2021 10-K 28 Jan 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.